The sale of Chemours Company's Glycolic Acid business to PureTech Scientific for $137 million is a significant transaction for the company. This deal is likely to have a positive impact on the company's financial position, leading to a rise in its share price. The news is directly related to Chemours Company (CC) and is important for investors, resulting in a score of 1, high relevance, importance, and confidence.